Keywords: aventis, andrx, pay, 80m, cardizem, settlement, corp
Aventis and Andrx to pay $80M in Cardizem settlement
Article | 03 February 2003
Andrx Corp has announced that, together with Aventis Pharmaceuticals, ithas entered into a settlement agreement in the Cardizem (diltiazem) CD ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
